ArticleACS omega2021
Targeted and Enhanced Antimicrobial Inhibition of Mesoporous ZnO-Ag
Article in ACS omega, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 83 citations in OpenAlex.
- Synthesis, Characterization, and Multifunctional Bioactivity of ZnO/CuO@Amoxicillin Nanocomposites: A Synergistic Nano-Platform With Potent Antioxidant, Anti-Inflammatory, Antidiabetic, and Anti-Cholinesterase Activities.Chemistry & biodiversity · 2026Article
- Dual-functional ZnO/g-CRSC advances · 2026Article
- Mn Doping Enhances the Antibacterial, Antibiofilm and Anti-Virulence Activity of ZnO Nanoparticles.Nanomaterials (Basel, Switzerland) · 2026Article
- Polymer-stabilized amorphous CuO-ZnO hybrid nanocomplex as a promising candidate for antimicrobial therapy and controlled drug delivery with molecular docking insights.Scientific reports · 2026Article
- Large enhancement in humidity sensing performance and photocatalytic efficiency of Ag-doped ZnO/GO nanocomposites.Scientific reports · 2026Article
- L-arginine functionalized NiFe₂O₄ nanoparticles: synthesis, characterization, antimicrobial activity, and biocompatibility evaluation in a zebrafish model.World journal of microbiology & biotechnology · 2026Article
- Article
- Exploring the antibacterial properties of ZnO nanorods-CuO nanoflowers: a mode of action approach.RSC advances · 2025Article
- Transforming henna: from natural dye to photosensitizer for efficient photocatalytic degradation of 4-nitrophenol using a green-synthesized ZnO@henna nanocomposite.RSC advances · 2025Article
- Zinc Oxide-Based Nanomaterials for Microbiostatic Activities: A Review.Journal of functional biomaterials · 2024Review
- Article
- Emerging Mesoporous Polyacrylamide/Gelatin-Iron Lanthanum Oxide Nanohybrids towards the Antibiotic Drugs Removal from the Wastewater.Nanomaterials (Basel, Switzerland) · 2023Article
- Article
- Novel imidazolium-thiohydantoin hybrids and their Mn(iii) complexes for antimicrobial and anti-liver cancer applications.RSC advances · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this work, mesoporous (pore size below 4 nm) composite nanoparticles of ZnO-Ag
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.